ROTA, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 7.667
EU - Europa 3.659
AS - Asia 1.126
AF - Africa 54
Continente sconosciuto - Info sul continente non disponibili 22
SA - Sud America 14
OC - Oceania 7
Totale 12.549
Nazione #
US - Stati Uniti d'America 7.498
IT - Italia 877
CN - Cina 695
SE - Svezia 596
DE - Germania 573
IE - Irlanda 469
UA - Ucraina 413
GB - Regno Unito 204
CA - Canada 162
HK - Hong Kong 149
VN - Vietnam 113
FI - Finlandia 108
RU - Federazione Russa 94
FR - Francia 83
IN - India 61
AT - Austria 54
DK - Danimarca 52
ZA - Sudafrica 50
BE - Belgio 40
NL - Olanda 40
TR - Turchia 31
KR - Corea 22
EU - Europa 16
SG - Singapore 16
JP - Giappone 13
ES - Italia 12
IR - Iran 12
GR - Grecia 9
BR - Brasile 6
CH - Svizzera 6
MX - Messico 6
A1 - Anonimo 4
AU - Australia 4
CO - Colombia 4
NO - Norvegia 4
PL - Polonia 4
CL - Cile 3
CZ - Repubblica Ceca 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
PH - Filippine 3
RO - Romania 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
IL - Israele 2
MY - Malesia 2
OM - Oman 2
PT - Portogallo 2
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
BZ - Belize 1
DZ - Algeria 1
EC - Ecuador 1
EG - Egitto 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
LI - Liechtenstein 1
LV - Lettonia 1
ME - Montenegro 1
MU - Mauritius 1
SC - Seychelles 1
SI - Slovenia 1
TH - Thailandia 1
Totale 12.549
Città #
Woodbridge 978
Ann Arbor 953
Houston 709
Fairfield 661
Chandler 605
Jacksonville 449
Dublin 447
Ashburn 379
Dearborn 369
Wilmington 312
Frankfurt am Main 297
New York 270
Seattle 263
Cambridge 257
Milan 244
Princeton 199
Hong Kong 140
Nanjing 136
Altamura 95
Lawrence 82
Lachine 81
Shanghai 75
Beijing 60
Nanchang 57
Dong Ket 55
Vienna 51
Cape Town 50
San Diego 48
Shenyang 46
Guangzhou 43
Andover 39
Hebei 37
Ottawa 34
Brussels 33
Tianjin 32
Jiaxing 28
Jinan 28
Helsinki 25
Philadelphia 25
Lissone 22
Mountain View 22
Changsha 21
Toronto 21
Fremont 20
Hangzhou 18
Zhengzhou 18
Boston 17
Boardman 16
London 16
Chicago 15
Bologna 14
Huizen 14
Ningbo 14
Nürnberg 14
Kunming 13
Manchester 13
Norwalk 13
Falls Church 9
Hanover 9
Hefei 8
Lanzhou 8
Los Angeles 8
Montréal 8
Pune 8
Edmonton 7
Fuzhou 7
Napoli 7
Padova 7
San Francisco 7
Stezzano 7
Taizhou 7
Torino 7
Verona 7
Bonndorf 6
Busto Arsizio 6
Rome 6
San Mateo 6
Washington 6
Bergamo 5
Foggia 5
Ozzano Monferrato 5
Valencia 5
Valmadrera 5
Brescia 4
Cagliari 4
Groningen 4
Hounslow 4
Indianapolis 4
Kyoto 4
Nottingham 4
Phoenix 4
Pioltello 4
Redmond 4
Seoul 4
Vancouver 4
Athína 3
Auburn Hills 3
Auckland 3
Central 3
Chiswick 3
Totale 9.232
Nome #
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 215
Trattamento con Sofosbuvir e Ribavirina nei pazienti hcv-positivi listati per il trapianto di fegato: un analisi di costo-efficacia 211
Continuous monitoring of cerebral blood flow (CBF) and cerebral temperature in neurocritical care unit 211
High-Resolution Intracranial Pressure Burden and Outcome in Subarachnoid Hemorrhage 187
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 185
Intracerebral hemorrhage in intensive care unit: early prognostication fallacies. A single center retrospective study 183
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 182
An Effective and Safe Strategy to Target Normothermia in Neurocritical Patients 173
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 172
Health Related Quality of Life in the Major Liver Conditions 169
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 169
Alcohol drinking and multiple myeloma risk - A systematic review and meta-analysis of the dose-risk relationship 169
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 168
Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation 167
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 166
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 165
Alcohol drinking and risk of renal cell carcinoma: results of a meta-analysis 163
Health related quality of life in chronic liver diseases 163
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 162
Should new antiviral treatments be considered in elderly Chronic Hepatitis C patients? 161
The impact of liver disease on the health-related quality of life 161
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 159
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 159
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 159
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 157
Should Sofosbuvir-Based All-Oral Treatment Be Considered In Elderly Chronic Hepatitis C Patients? 157
Alcohol drinking and non-Hodgkin lymphoma risk: a systematic review and a meta-analysis 154
Alcohol drinking and esophageal squamous cell carcinoma with focus on light-drinkers and never-smokers - A systematic review and meta-analysis 151
A noninvasive index of atrial remodeling in patients with paroxysmal and persistent atrial fibrillation: a pilot study 151
Modelling body mass index and endometrial cancer risk in a pooled-analysis of three case-control studies 151
Re: light drinking has positive public health consequences 150
Alcohol consumption and site-specific cancer risk: A comprehensive dose-response meta-analysis 150
A meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma risk 149
Light alcohol drinking and cancer: a meta-analysis 149
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 149
Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies 148
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 148
A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 1: Overall results and dose-risk relation 148
Alcohol consumption and lung cancer risk in never smokers: a meta-analysis 147
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 147
Random-effects meta-regression models for studying nonlinear dose-response relationship, with an application to alcohol and esophageal squamous cell carcinoma 146
The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation 143
Alcohol drinking and laryngeal cancer: Overall and dose-risk relation - A systematic review and meta-analysis 142
Single-Incision Versus Standard Multiple-Incision Laparoscopic Cholecystectomy: A Meta-analysis of Experimental and Observational Studies 142
A meta-analysis on alcohol drinking and gastric cancer risk 142
Is multifocality a prognostic factor in childhood hepatoblastoma? 142
Alcohol drinking and cutaneous melanoma risk: A systematic review and dose-risk meta-analysis 140
A prospective evaluation of short-term and long-term results from colonic stenting for palliation or as a bridge to elective operation versus immediate surgery for large-bowel obstruction 139
External Ventricular and Lumbar Drain Device Infections in ICU Patients: A Prospective Multicenter Italian Study 139
A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 2: Results by subsites 138
Organ donation after brain death in refractory cardiac arrest treated with extracorporeal CPR 138
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 136
Alcohol drinking and epithelial ovarian cancer risk. A systematic review and meta-analysis 136
Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis 133
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 133
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 133
Incidence of pain after craniotomy in children 132
Management of Chronic hepatitis C (CHC) Genotype 1 treatment-naive patients in an era of rising opportunities and costs - A cost-effectiveness analysis of treatment options 132
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 132
Alcohol consumption and prostate cancer risk: a meta-analysis of the dose-risk relation 128
Finding the optimal cut-point for Gaussian and Gamma distributed biomarkers 126
A meta-analysis on alcohol drinking and the risk of Hodgkin lymphoma 125
A meta-analysis of alcohol consumption and the risk of brain tumours 124
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 121
Trajectories of early secondary insults after traumatic brain injury: a new approach to evaluate impact on outcome 120
Cost-effectiveness of Sofosbuvir plus Ledipasvir Antiviral Treatment for Elderly Patients with Chronic Hepatitis C Genotype 1 119
Trajectories of early secondary insults correlate to outcomes of traumatic brain injury: results from a large, single centre, observational study 117
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 117
Incidence of inhibitors to recombinant factor VIII products – A meta-analysis of 1,852 previously untreated patients 116
Meta-analysis on incidence of inhibitors in patients with haemophilia A treated with recombinant factor VIII products 112
Organ donation in cardiac arrest patients treated with extracorporeal CPR: A single centre observational study 112
Optimal cut-point definition in biomarkers: The case of censored failure time outcome 109
Strong excess risk of pancreatic cancer for low frequency and duration of cigarette smoking: A comprehensive review and meta-analysis 106
A random-effects meta-regression model for studying nonlinear dose-response relationship 103
Alcohol drinking and risk of leukemia-A systematic review and meta-analysis of the dose-risk relation 102
A simulation study comparing performance of minimum P-value and Youden index as methods to find optimal cut-points of continuous variables 101
Thromboembolic event rate in patients exposed to anti-inhibitor coagulant complex: a meta-analysis of 40-year published data 99
Cut-Point Finding Methods For Continuous Biomarkers In The Presence Of Binary And Censored Failure Time Outcome 98
Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies 98
Prospective multicentre cohort study evaluating the incidence of pain after craniotomy in children: first interim analysis. 98
Cost-effectiveness of new direct-acting antivirals to prevent post-liver transplant recurrent hepatitis 98
Donor safety in living donor liver donation: An Italian multicenter survey 97
Sofosbuvir and ribavirinin in HCV-infected patients listed for liver transplantation: A cost-effectiveness analysis 95
Difference in health related quality of life of chronic liver diseases and general population 95
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using “on demand” Approach: A Single Center Experience 94
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 94
Is there a difference in inhibitor incidence with recombinant products? A meta-analysis of 2000 previously untreated patients 91
Cut-pont finding methods for continuous biomarkers 87
Meta-Analysis on Incidence of Inhibitors in 1,945 Previously Untreated Patients Treated with Recombinant Factor VIII Products: Is There a Difference? 85
Coffee consumption and risk of fractures: A systematic review and dose-response meta-analysis 84
Quantifying the Dose-Response Relationship Between Circulating Folate Concentrations and Colorectal Cancer in Cohort Studies: A Meta-Analysis Based on a Flexible Meta-Regression Model 83
Intracranial pressure monitor insertion in traumatic brain injury: a single center, retrospective decision process analysis 75
Cut-point identification in biomarkers for a censored failure time outcome 71
Factors influencing the decision to monitor intracranial pressure in traumatic brain injury. A large monocentric study 70
Cut-point identification in biomarkers for a censored failure time outcome 69
Dose-response relationship between cigarette smoking and site-specific cancer risk: Protocol for a systematic review with an original design combining umbrella and traditional reviews 66
Does alcohol consumption increase the risk of cutaneous melanoma? Comments on a recent meta-analysis: reply from the authors 64
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using" on demand" Approach: A Single Center Experience 62
Incidence of Thrombo-Embolic Events in Relation to Activated Prothrombin Complex Concentrate Exposure: A Literature Meta-Analysis 55
Totale 13.089
Categoria #
all - tutte 34.195
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.195


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019820 0 0 0 0 0 0 0 0 71 144 256 349
2019/20202.697 373 154 207 197 263 340 398 174 225 151 155 60
2020/20211.267 93 83 152 160 84 75 81 88 103 144 47 157
2021/2022954 40 79 109 98 33 90 29 78 50 84 71 193
2022/20232.231 232 687 171 198 134 338 26 147 180 8 92 18
2023/20241.410 55 72 54 93 176 520 273 75 92 0 0 0
Totale 13.089